Oral presentation: "NEURONET and public-private partnerships in research". L. Killin (Parkinson's Research in Ireland), 7 April 2022, Virtual. Recording
Oral presentation: “Gaps, Challenges And Priorities For Neurodegenerative Disease Research And Health Technology Assessment”. NICE (HTAi 2022 Conference), 28 June 2022, Utrecht (Netherlands).
Oral presentations as part of our public event during the 31st Alzheimer Europe Conference (virtual) from 29 November to 1 December:
Elevating the patient voice: public involvement in Innovative Medicines Initiative neurodegeneration projects
Collaboration and best practice: common challenges & lessons learned from the Innovative Medicines Initiative neurodegeneration portfolio
From bench to bedside: preclinical research in Innovative Medicines Initiative neurodegeneration projects
Looking to the future: Impact of the Innovative Medicines Initiative’s neurodegeneration portfolio
Oral presentation: "Lessons learned from IMI funded projects – the findings of the Neuronet consortium and the IMI neurodegeneration portfolio'". C. Diaz (European Parliament Workshop), 28 September 2021, Virtual. Recording
Oral presentation: "How IMI projects have addressed the challenge & 'moved the needle'". C. Diaz (IMI Impact on dementia), 15 June 2021, Virtual. Presentation Recording
Oral presentation: “National approaches to pricing, reimbursement and health technology assessments”. NICE (Virtual Alzheimer’s Association Academy meeting), 13 July 2021, Virtual.
Oral presentation: "Adopting best practice on data sharing: report on Neuronet Working Group activities". M. Rinaldi & L. Steukers (Alzheimer Europe Conference 2020), 20-22 October 2020, Virtual.
Oral presentation: "Adopting best practice on patient privacy – report on Neuronet Working Group activities". A. Bradshaw (Alzheimer Europe Conference 2020), 20-22 October 2020, Virtual.
Oral presentation: "A framework for regulatory and health technology assessment engagement in neurodegenerative disease research". D. O'Rourke & J. Bouvy (Alzheimer Europe Conference 2020), 20-22 October 2020, Virtual.
Oral presentation: "The neurodegeneration portfolio of the Innovative Medicines Initiative – from project results to sustainable assets". C. Diaz, S. Pla, J. Georges, A. Bradshaw, J. Bouvy, D. O'Rourke, L. Pradier, M. Rinaldi & L. Steukers. (Alzheimer Europe Conference 2020), 20-22 October 2020, Virtual.
Poster presentation: "Regulatory and HTA Engagement in Neurodegenerative Disease Research: A Decision Tool". D. O'Rourke, P. Jonsson and J. Bouvy (ISPOR Europe 2019), 2-7 November 2019, Copenhagen (Denmark).
Oral presentation: "Neuronet – Efficiently Networking European Neurodegeneration Research”. C. Diaz, S. Pla, N. Coll, J. Georges, J. Bouvy, H. Marston, L. Pradier, A. Roach, M. Traber, E. Merlo-Pich and D. Pemberton (Alzheimer Europe Conference 2019), 23-25 October 2019, The Hague (Netherlands).